COGT — COGENT BIOSCIENCES INC

Ownership history in EMERALD ADVISERS, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which EMERALD ADVISERS, LLC reported a position in COGENT BIOSCIENCES INC (COGT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.73% (2025 Q4)
Avg. % of fund
0.95%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 1,583,346 +3,850 +0.2% 1.73% $56.2M $35.52
2025 Q3 ADDED 1,579,496 +133,722 +9.2% 0.73% $22.7M $14.36
2025 Q2 INITIATED 1,445,774 — — 0.38% $10.4M $7.18
% of Fund (quarterly)    COGT price (monthly, adj. close)

Other funds also holding COGT

As of 2025 Q4 — sorted by position size

Fairmount Funds Management LLC 3Y 24.34% Kynam Capital Management, LP 3Y 13.99% Elmind Capital, LP 12.27% Octagon Capital Advisors LP 3Y 10.13% Saturn V Capital Management LP 3Y 7.93% SUPERSTRING CAPITAL MANAGEMENT LP 6.96% TCG Crossover Management, LLC 3Y 6.9% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 6.14% Vivo Capital, LLC 3Y 7Y 5.51% Commodore Capital LP 3Y 5.19%
← Back to EMERALD ADVISERS, LLC Holdings